ArticlePharmaceutics2022

Anti PD-1/Anti PDL-1 Inhibitors in Advanced Gastroesophageal Cancers: A Systematic Review and Meta-Analysis of Phase 2/3 Randomized Controlled Trials.

Kanak Parmar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.